Diagnosis and treatment of apolipoprotein B dyslipoproteinemias.
about
C to U RNA editing mediated by APOBEC1 requires RNA-binding protein RBM47Long-term Expression of Apolipoprotein B mRNA-specific Hammerhead Ribozyme via scAAV8.2 Vector Inhibits Atherosclerosis in Mice.Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis.Apolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretion.Genetic determinants of plasma triglyceridesEffects of an isocaloric healthy Nordic diet on insulin sensitivity, lipid profile and inflammation markers in metabolic syndrome -- a randomized study (SYSDIET).Genomic Variants Associated with Resistance to High Fat Diet Induced Obesity in a Primate Model.Why, when and how should hypertriglyceridemia be treated in the high-risk cardiovascular patient?Surgical inflammatory stress: the embryo takes hold of the reins again.Demystifying the management of hypertriglyceridaemia.ApoB versus non-HDL-cholesterol: diagnosis and cardiovascular risk management.Membrane Protein Quantity Control at the Endoplasmic Reticulum.Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-C.Effects of blood lipid stability on progression of carotid atherosclerosis.Re-editing the paradigm of Cytidine (C) to Uridine (U) RNA editing.Establishing cut-off values for apolipoprotein B and non-HDL-C according to LDL-C values in a South European population.Application and validation of a diagnostic algorithm for the atherogenic apoB dyslipoproteinemias: ApoB dyslipoproteinemias in a Dutch population-based study.Influence of APOE-2 genotype on the relation between adiposity and plasma lipid levels in patients with vascular disease
P2860
Q28588982-340B17DF-9D30-4C1B-A010-7426EE760C68Q33635929-6ED9880F-5543-45BE-9F04-AA402FF9407BQ33724815-C039242D-5B14-468B-A880-C8B3E025EE05Q33858526-74FAE407-7140-4E54-9ACD-820E0DE4DB8BQ34503333-9FCAE826-F5EC-472E-A1B5-92AAD8F3FB60Q37110911-4F0D3AAD-1855-4075-AECA-FFE8FD837E57Q37394261-C731381B-1D27-4EEE-9CB1-DD6CFBF00839Q37923968-E6489A12-1D20-4CBD-BF11-A25C03733522Q38078558-7C6427CF-E913-4C11-9F41-59B29472E2B9Q38141575-F226BC43-B165-48F3-81D3-782DED87D20BQ38167825-C501950F-1EDD-4659-A649-1569CC1E223CQ38981333-C6A82B1D-D8C3-44F8-8862-D0EB95461D09Q39045940-7A838884-4EE8-4BDE-AAC1-880E335FB40AQ41012566-FB966E59-BE64-4930-ABE7-1A4494318201Q43206599-95E9D7FF-9CF2-4B89-BD0D-981DCA277915Q44776392-76EF192D-C573-4D26-97D6-C1DFC20215A0Q44920123-3C5F9412-5F18-4DD9-B349-61C8719FC323Q57316342-C249E4CF-8A51-4DC9-BE76-5290E45B69C0
P2860
Diagnosis and treatment of apolipoprotein B dyslipoproteinemias.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Diagnosis and treatment of apolipoprotein B dyslipoproteinemias.
@en
Diagnosis and treatment of apolipoprotein B dyslipoproteinemias.
@nl
type
label
Diagnosis and treatment of apolipoprotein B dyslipoproteinemias.
@en
Diagnosis and treatment of apolipoprotein B dyslipoproteinemias.
@nl
prefLabel
Diagnosis and treatment of apolipoprotein B dyslipoproteinemias.
@en
Diagnosis and treatment of apolipoprotein B dyslipoproteinemias.
@nl
P2860
P356
P1476
Diagnosis and treatment of apolipoprotein B dyslipoproteinemias
@en
P2093
Allan Sniderman
Jacqueline de Graaf
P2860
P2888
P304
P356
10.1038/NRENDO.2010.50
P577
2010-04-27T00:00:00Z